THE RIGHT
TIME
The market for functional health solutions is growing dynamically. Demand for scientifically validated, highly bioavailable active ingredient systems is increasing. Swiss Molecular Services AG operates at this intersection with a five-time patented micellar technology.
Highly bioavailable. Stable. Scalable.
-
scientifically validated
-
modular application
-
cross-product integration
-
internationally scalable
An IP-protected platform with repeatable monetization across multiple markets.
MARKET & REVENUE POTENTIAL
Scaling is achieved through a combination of product innovation, distribution partnerships, and platform licensing. Regional market entry is structured and implemented in a phased approach:
GERMANY, AUSTRIA & SWITZERLAND
Year 1 15 Mio.
Year 3 50 Mio.
Year 5 120 Mio.
EUROPE
Year 1 8 Mio.
Year 3 30 Mio.
Year 5 80 Mio.
ASIA / CHINA
Year 1 40 Mio.
Year 3 100 Mio.
VALUE CREATION & GROWTH STRATEGY
MONETIZATION MODEL
Recurring revenue streams and high scalability.
Value creation through three key drivers:
-
proprietary product lines (B2C & B2B)
-
technology licensing
-
strategic partnerships
SCALABLE GROWTH MODEL
Vertically integrated platform – from development to market launch.
Scaling through:
-
portfolio expansion
-
international expansion
-
licensing and technology partnerships
VALUE CREATION POTENTIAL
Attractive risk-reward profile for long-term investors:
-
IP-protected technology
-
expansion of global market share
-
strategic exit opportunities